Forager fund L.P. disposes of $1.93 million in Repay Holdings (RPAY)

Forager Fund L.P. sold 642,837 RPAY Class A shares across Mar 25-27 for $1.93M (prices ~$2.82–$3.07), leaving a direct stake of 9,242,937 shares. Repay reported Q4 2025 EPS $0.19 vs $0.17 consensus and revenue $78.6M vs $76.8M, market cap $267M; shares have been volatile (up 18% past week, down 41% over six months). Despite the insider disposals, InvestingPro flags RPAY as undervalued and some analysts have upgraded or adjusted outlooks, indicating a modestly positive fundamental view but continued price volatility.

Analysis

Small-cap payments names with concentrated ownership profiles behave like illiquid option contracts: modest incremental selling or buying produces outsized headline volatility and forces short-term technical moves that can diverge from fundamentals for weeks. Improved quarterly execution can spark momentum-driven rerating, but with limited float the path to realizing that rerating is jagged — expect 10–30% intraday/weekly swings around earnings, analyst notes, or block trades.

On competitive dynamics, the leverage point is scale in processing and embedded services (tokenization, white‑label lending, fraud tools). Firms that can convert transactional revenue into higher-margin SaaS-like annuities will widen economic moats; conversely, legacy acquirers or global processors with deeper balance sheets can compress pricing quickly via bundled products or cross-subsidized customer wins, making medium-term margin expansion non-linear.

Key tail risks are merchant-concentration churn, a single large client attrition event, or a material security/operational failure; these cut TPV and revenue almost immediately and would reset multiples within days. Near-term catalysts to monitor are subsequent quarterly cadence, any sign of recurring revenue mix improvement, and sale/strategic-process rumors — each has the power to move the stock sharply in a 3–12 month window.

Contrarian read: market attention is fixated on headline flows and short-term volatility, understating the chance of a strategic outcome (tuck‑in M&A or reclassification toward higher recurring revenue) that could re-rate the company. Conversely, consensus may also be underestimating execution risk — if management fails to sustain margin progress, downside could be swift and deep, so position sizing and optionality are key.

Key Decisions for Investors

• Opportunistic long equity (RPAY): initiate a small, size-constrained position (1–2% NAV) on a >10% pullback from recent levels, horizon 6–12 months. Use a 25% stop-loss and target 50–100% upside if recurring revenue mix or TPV growth accelerates or if strategic interest emerges.
• Directional options (RPAY): buy a 6-month call spread (buy ~15% OTM, sell ~40–50% OTM) to express a re-rating/M&A upside with defined max loss = premium; aim for 2–3x return if a positive catalyst prints while limiting capital at risk.
• Pair trade to isolate company vs sector: long RPAY / short FISV (or GPN) sized to neutralize payments-volume beta, horizon 6–12 months. This isolates idiosyncratic upside from re-rating or M&A while protecting against a broad payments rally (stop-loss if pair P&L down 12%).
• Event-driven accumulation: scale into position on confirmed insider buying, a clear upgrade cycle from multiple sell‑side firms, or a sequential margin beat; avoid buying into headline-driven spikes — take profits incrementally after 30–50% moves.